541400 Stock Overview
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally.
ZIM Laboratories Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹323.45|
|52 Week High||₹388.00|
|52 Week Low||₹109.10|
|1 Month Change||25.93%|
|3 Month Change||23.41%|
|1 Year Change||176.69%|
|3 Year Change||306.60%|
|5 Year Change||n/a|
|Change since IPO||208.86%|
Recent News & Updates
|541400||IN Pharmaceuticals||IN Market|
Return vs Industry: 541400 exceeded the Indian Pharmaceuticals industry which returned -3.2% over the past year.
Return vs Market: 541400 exceeded the Indian Market which returned 7.2% over the past year.
|541400 Average Weekly Movement||7.1%|
|Pharmaceuticals Industry Average Movement||5.0%|
|Market Average Movement||5.6%|
|10% most volatile stocks in IN Market||9.1%|
|10% least volatile stocks in IN Market||3.6%|
Stable Share Price: 541400 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 541400's weekly volatility (7%) has been stable over the past year.
About the Company
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements.
ZIM Laboratories Limited Fundamentals Summary
|541400 fundamental statistics|
Is 541400 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|541400 income statement (TTM)|
|Cost of Revenue||₹1.96b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||13.36|
|Net Profit Margin||5.65%|
How did 541400 perform over the long term?See historical performance and comparison